Illustrative image – not actual.US drug maker Pfizer is closing down two manufacturing plants in India that make generic injectables like penicillin in response to falling demand. The plant in Chennai makes generic injectable cephalosporin, penems and penicillin.
The Maharashtra plant supplied the Chennai unit with certain products. Both plants do not manufacture products for the India market. The company, on the other hand, is expanding operations in its Visakhapatnam facility in Andhra Pradesh.
Pfizer acquired the sites as part of its USD 15 billion purchase of Hospira in 2015, to boost its portfolio of generic injectable drugs and copies of bio-tech medicines. The company employs around 1,700 workers at the two factories in the states of Tamil Nadu and Maharashtra.
